Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Mar 30 2023

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-30-2023-7

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 30, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Brimonidine Tartrate Ophthalmic Solution, 0.15%.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases